Appeals that reach the independent reviewer
i
CMS's quarterly Part C reconsideration fact sheets, published about three months after each quarter. We read two tables from each: decisions by priority, and decisions by type of appeal and item or service (favorable, partially favorable, unfavorable). Every line is checked against the text of the fact sheet.
"Overturned" means the IRE decided fully or partly in the member's favor. Rates are overturned decisions ÷ decisions on the merits; dismissed and withdrawn cases aren't counted. On a few lines a year CMS's counts don't add up to the total it prints; we use the counts, which match its printed percentages.
The IRE changed on May 1, 2026, from Maximus Federal Services to C2C Innovative Solutions. The fact sheets are Maximus's through Q1 2026 and C2C's from Q2 2026. C2C sorts appeals into a different set of service types and items (for example Dental, Diagnostic Imaging and Hospital Inpatient, where Maximus had Supplemental Benefit, Imaging and Inpatient Hospital), so the tables by service and by item show each contractor's categories on their own and never join them into one series, even where a name is the same. The priorities (expedited, pre-service, retrospective) are the same under both, so that chart runs on across the change, which is marked on it.
Two levels of appeal, 2025
| Level | Who decides | Appeals decided | Approved or overturned |
|---|---|---|---|
| 1. Plan reconsideration | The plan itself, on its own prior authorization denials | 208,679218 contracts, 31 parents | 59.9%"approved after appeal" |
| 2. Independent review | The IRE, on every denial the plan upheld (standard pre-service) | 43,073nationwide | 5.1%overturned |
| 2. Independent review, all | The IRE, all priorities (expedited, pre-service, payment) | 282,578 | 3.3% |
Most prior authorization denials that are appealed are reversed by the plan itself; the IRE overturns only a small share of the rest.
Level 1 is what plans post under 42 CFR 422.122(c): the share of their standard prior authorization appeals they approved in 2025, from the plans' reports that give it as a share of decided appeals and print the number of appeals. Plans that divide by all denials or don't say are left out. Level 2 is the IRE's decisions in the four quarters of 2025. "Standard pre-service" cases are requests for care not yet given, which is closest to prior authorization; the IRE also decides expedited requests and appeals of payment for care already given ("retrospective"). The two levels don't cover exactly the same cases: plan figures exclude drugs and are only from plans we've found reports for, and the IRE sees a case only after the plan has upheld its denial. An overturn can follow new information, so it doesn't by itself mean the first decision was wrong.i
Overturn rate over time
By priority i
PrioritiesExpedited: urgent requests, decided within 72 hours. Pre-Service: standard requests for care not yet given. Retrospective: payment for care already given. Part B drug pre-service appeals are a separate, smaller line in the fact sheets and are left off this chart.
i
Expedited: urgent requests, decided within 72 hours. Pre-Service: standard requests for care not yet given. Retrospective: payment for care already given. Part B drug pre-service appeals are a separate, smaller line in the fact sheets and are left off this chart.
The dashed line marks the change of IRE from Maximus to C2C.
Five largest services, Maximus's categories, Q1 2021 to Q1 2026
C2C's service types start in Q2 2026; this chart switches to them once there's a year of quarters.
By type of service
Share of the IRE's decisions that overturned the plan, by the type of service appealed. Each IRE uses its own service types, so each has its own table, newest first. Darker cells are overturned more often; hover a cell for the number of decisions.
C2C's service types, Q2 2026
| Service | DecidedQ2 2026 | OverturnedQ2 2026 |
|---|---|---|
| Other | 25,267 | 2.0% |
| Laboratory | 9,353 | 2.9% |
| Physician Services | 8,952 | 4.7% |
| Hospital Inpatient | 7,146 | 4.5% |
| DME | 7,056 | 2.6% |
| Dental | 5,688 | 3.1% |
| Non-MD Practitioner | 5,496 | 2.3% |
| Drugs | 2,733 | 4.9% |
| Diagnostic Imaging | 2,540 | 6.7% |
| Home Health | 1,846 | 1.4% |
| Transportation | 1,542 | 2.3% |
| Skilled Nursing Facility | 1,030 | 1.7% |
| Emergency | 566 | 1.9% |
| Vision Care | 381 | 3.4% |
| Out of Area | 5 | 20.0% |
| Medical Supplies | 2 | 0.0% |
| Prosthetics/Orthotics | 1 | 0.0% |
Maximus's service types, Q1 2021 to Q1 2026
| Service | DecidedQ2 2025 to Q1 2026 | OverturnedQ2 2025 to Q1 2026 | Changevs 4 quarters before | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inpatient Hospital | 53,046 | 2.1% | +0.4 pts | 2.7% | 4.8% | 4.6% | 2.2% | 1.9% | 2.0% | 1.5% | 1.8% | 1.6% | 1.9% | 1.7% | 3.1% |
| Practitioner Services | 47,346 | 3.4% | +0.5 pts | 5.9% | 4.8% | 4.3% | 4.1% | 3.0% | 3.1% | 2.8% | 2.8% | 3.7% | 3.2% | 3.4% | 3.2% |
| DME/ Orthotics | 39,278 | 3.4% | −0 pts | 4.8% | 6.5% | 6.2% | 2.8% | 3.2% | 4.1% | 3.2% | 3.2% | 4.3% | 2.9% | 3.3% | 3.1% |
| Lab | 38,902 | 2.6% | −0.3 pts | 7.0% | 5.9% | 5.4% | 5.3% | 2.9% | 3.2% | 2.7% | 2.9% | 2.5% | 2.4% | 3.1% | 2.5% |
| Supplemental Benefit | 35,757 | 2.2% | −1.2 pts | 4.5% | 3.8% | 3.1% | 2.8% | 3.0% | 3.3% | 3.6% | 3.7% | 2.5% | 2.4% | 1.9% | 2.0% |
| Surgery | 22,886 | 7.2% | +2.8 pts | 5.6% | 4.8% | 4.7% | 5.0% | 3.4% | 6.0% | 3.7% | 4.4% | 6.7% | 7.3% | 6.9% | 8.0% |
| Drugs | 10,107 | 5.6% | +0.5 pts | 7.4% | 8.3% | 6.9% | 5.2% | 6.5% | 6.2% | 4.1% | 4.3% | 5.1% | 5.8% | 5.7% | 5.7% |
| Imaging | 9,498 | 8.9% | +0.4 pts | 9.2% | 10.5% | 9.2% | 7.3% | 6.5% | 9.3% | 8.9% | 8.8% | 9.9% | 8.6% | 8.6% | 8.6% |
| Skilled Nursing Facility | 7,368 | 2.1% | −0.6 pts | 5.8% | 5.8% | 4.9% | 3.8% | 3.4% | 3.8% | 2.1% | 2.1% | 2.4% | 2.6% | 1.8% | 1.7% |
| Home Health | 6,519 | 2.6% | −0.9 pts | 4.1% | 4.5% | 3.7% | 4.6% | 3.8% | 3.8% | 3.5% | 3.1% | 2.9% | 2.2% | 2.6% | 2.6% |
| Testing | 4,736 | 3.3% | −0.6 pts | 6.9% | 8.9% | 6.9% | 4.6% | 4.3% | 3.8% | 3.6% | 3.8% | 3.2% | 3.2% | 3.7% | 2.9% |
| Transportation | 4,163 | 4.7% | −0.6 pts | 4.5% | 4.5% | 4.6% | 3.4% | 3.1% | 5.5% | 7.6% | 5.0% | 5.4% | 4.2% | 4.3% | 5.0% |
| Outpatient Therapies | 3,759 | 3.4% | −0.4 pts | 7.4% | 7.1% | 5.3% | 2.6% | 3.5% | 4.9% | 3.6% | 3.5% | 3.4% | 2.1% | 3.1% | 4.9% |
| Step-Therapy | 3,410 | 1.6% | −0.4 pts | 2.7% | 2.9% | 1.7% | 1.3% | 1.7% | 2.0% | 2.3% | 1.7% | 1.8% | 2.4% | 1.2% | 0.9% |
| ER | 3,072 | 2.5% | −3.1 pts | 6.7% | 5.9% | 6.3% | 5.2% | 9.9% | 8.6% | 2.2% | 2.1% | 2.2% | 2.4% | 2.7% | 2.7% |
| Outpatient Mental Health | 3,059 | 1.2% | −0.5 pts | 7.2% | 2.1% | 1.6% | 0.7% | 3.4% | 1.9% | 1.6% | 0.6% | 1.2% | 1.6% | 1.1% | 1.1% |
| Hospice | 893 | 1.5% | +0.4 pts | 0.7% | 1.3% | 1.5% | 1.9% | 1.8% | 2.4% | 0.4% | 0.3% | 1.4% | 1.0% | 1.7% | 1.7% |
| Other | 282 | 0.0% | −0.6 pts | 5.6% | 3.4% | 1.8% | 1.0% | 0.6% | 1.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
"Supplemental Benefit" covers benefits Original Medicare doesn't, mostly dental. "Step-Therapy" is appeals of a requirement to try another drug first.
By item or service
Each IRE's last four quarters (C2C: Q2 2026; Maximus: Q2 2025 to Q1 2026). Items are listed under the IRE whose fact sheets name them.
| Item or service | Type of service | IRE | Decided | Overturned | Rate |
|---|---|---|---|---|---|
| Other treatments | Physician Services | C2C | 8,729 | 397 | 4.5% |
| Observation inpatient | Hospital Inpatient | C2C | 6,709 | 294 | 4.4% |
| Acute rehabilitation | Other | C2C | 6,577 | 72 | 1.1% |
| Miscellaneous services | Dental | C2C | 5,658 | 175 | 3.1% |
| Other tests - Other | Laboratory | C2C | 3,798 | 72 | 1.9% |
| Other lab tests | Laboratory | C2C | 3,373 | 148 | 4.4% |
| Routine office visit | Non-MD Practitioner | C2C | 3,194 | 37 | 1.2% |
| Other treatments | Other | C2C | 2,773 | 86 | 3.1% |
| Monitoring equipment, blood glucose monitors | DME | C2C | 2,322 | 33 | 1.4% |
| specialist services | Other | C2C | 2,254 | 73 | 3.2% |
| Miscellaneous equipment | DME | C2C | 2,043 | 60 | 2.9% |
| Home Health Nursing | Home Health | C2C | 1,813 | 20 | 1.1% |
| Monitoring equipment, blood glucose monitors | Other | C2C | 1,739 | 10 | 0.6% |
| Specific Drug | Drugs | C2C | 1,585 | 91 | 5.7% |
| Imaging - other | Diagnostic Imaging | C2C | 1,454 | 90 | 6.2% |
| Long-tern acute care | Other | C2C | 1,330 | 7 | 0.5% |
| Automated general profiles | Laboratory | C2C | 1,209 | 15 | 1.2% |
| Continued Stay at SNF | Skilled Nursing Facility | C2C | 1,007 | 17 | 1.7% |
| Power Operated Vehicle | DME | C2C | 965 | 34 | 3.5% |
| Other treatments | Non-MD Practitioner | C2C | 958 | 57 | 5.9% |
| Consultation | Other | C2C | 803 | 12 | 1.5% |
| Physical Therapy | Non-MD Practitioner | C2C | 770 | 25 | 3.2% |
| Imaging - other | Laboratory | C2C | 733 | 26 | 3.5% |
| Other transportation | Transportation | C2C | 728 | 3 | 0.4% |
| Other transportation | Other | C2C | 719 | 1 | 0.1% |
| Emergency services | Emergency | C2C | 566 | 11 | 1.9% |
| Emergency ambulance | Transportation | C2C | 539 | 13 | 2.4% |
| Advanced imaging - CAT: other | Diagnostic Imaging | C2C | 533 | 36 | 6.8% |
| Miscellaneous equipment | Other | C2C | 531 | 8 | 1.5% |
| Admission to SNF | Other | C2C | 514 | 16 | 3.1% |
| Pneumatic compressor and appliances | DME | C2C | 474 | 11 | 2.3% |
| Miscellaneous | Drugs | C2C | 456 | 7 | 1.5% |
| Non-emergency ambulance | Other | C2C | 436 | 2 | 0.5% |
| OTC | Drugs | C2C | 406 | 3 | 0.7% |
| Imaging - other | Other | C2C | 390 | 26 | 6.7% |
| Vision aids | Vision Care | C2C | 380 | 13 | 3.4% |
| Biologic and immunologic agents | Other | C2C | 376 | 8 | 2.1% |
| Other lab tests | Other | C2C | 362 | 4 | 1.1% |
| Acupuncture | Non-MD Practitioner | C2C | 329 | 3 | 0.9% |
| Acute rehabilitation | Hospital Inpatient | C2C | 323 | 15 | 4.6% |
| Home Health Nursing | Other | C2C | 322 | 4 | 1.2% |
| Miscellaneous | Other | C2C | 279 | 4 | 1.4% |
| Leg orthosis | DME | C2C | 265 | 7 | 2.6% |
| Wheelchair accessories | Other | C2C | 251 | 4 | 1.6% |
| Urinalysis | Laboratory | C2C | 239 | 6 | 2.5% |
| Observation inpatient | Other | C2C | 237 | 5 | 2.1% |
| Non-emergency ambulance | Transportation | C2C | 215 | 11 | 5.1% |
| Inpatient diagnostic | Other | C2C | 213 | 7 | 3.3% |
| Crowns | Other | C2C | 206 | 10 | 4.9% |
| Back Brace | DME | C2C | 204 | 1 | 0.5% |
| Pneumatic compressor and appliances | Other | C2C | 202 | 2 | 1.0% |
| Advanced imaging - MRI: other | Diagnostic Imaging | C2C | 196 | 21 | 10.7% |
| Oxygen & related respiratory equipment | DME | C2C | 187 | 7 | 3.7% |
| Home Health PT/OT | Other | C2C | 182 | 1 | 0.5% |
| Inpatient Psych | Other | C2C | 180 | 15 | 8.3% |
| Orthopedic Footwear (shoes, supports, lifts wedges, etc.) | DME | C2C | 171 | 5 | 2.9% |
| Wheelchairs | DME | C2C | 170 | 10 | 5.9% |
| Wheelchair - motorized | Other | C2C | 168 | 9 | 5.4% |
| preventive medicine services | Non-MD Practitioner | C2C | 167 | 4 | 2.4% |
| Miscellaneous services | Other | C2C | 166 | 0 | 0.0% |
| Antineoplastic agents | Other | C2C | 166 | 4 | 2.4% |
| Diagnostic services | Other | C2C | 163 | 5 | 3.1% |
| Inpatient intensive care | Other | C2C | 161 | 10 | 6.2% |
| Antirheumatic Agents (e.g. Methotrexate) | Other | C2C | 155 | 1 | 0.6% |
| Physical Therapy | Other | C2C | 154 | 1 | 0.6% |
| Dental surgical procedures | Other | C2C | 150 | 6 | 4.0% |
| Imaging - other | Physician Services | C2C | 146 | 18 | 12.3% |
| Surgical Assist | Other | C2C | 141 | 8 | 5.7% |
| Echography - heart | Diagnostic Imaging | C2C | 138 | 4 | 2.9% |
| Dentures | Other | C2C | 128 | 1 | 0.8% |
| Other tests - Other | Other | C2C | 122 | 3 | 2.5% |
| Standard imaging - nuclear medicine | Diagnostic Imaging | C2C | 121 | 16 | 13.2% |
| Advanced imaging - CAT: other | Other | C2C | 116 | 3 | 2.6% |
| Transcutaneous and/or Neuromuscular Electrical Nerve Stimulators | Other | C2C | 113 | 2 | 1.8% |
| Chemotherapy agents | Other | C2C | 108 | 4 | 3.7% |
| Power Operated Vehicle | Other | C2C | 101 | 1 | 1.0% |
| Chemotherapy agents | Drugs | C2C | 99 | 19 | 19.2% |
| Hematological agents | Other | C2C | 95 | 0 | 0.0% |
| Standard imaging - breast | Diagnostic Imaging | C2C | 91 | 2 | 2.2% |
| Suction Pump/room vaporizers, CPAP device | DME | C2C | 86 | 3 | 3.5% |
| Oxygen & related respiratory equipment | Other | C2C | 80 | 3 | 3.8% |
| Gastrointestinal agents | Other | C2C | 80 | 2 | 2.5% |
| Vitamins, Minerals, Electrolytes | Other | C2C | 71 | 1 | 1.4% |
| Central nervous system | Other | C2C | 68 | 1 | 1.5% |
| Endocrine/Metabolic | Other | C2C | 68 | 2 | 2.9% |
| Topical Ophthalmic (eye) or otic (ear) agents | Other | C2C | 65 | 0 | 0.0% |
| Biologic and immunologic agents | Drugs | C2C | 64 | 4 | 6.2% |
| Long-tern acute care | Hospital Inpatient | C2C | 60 | 4 | 6.7% |
| Advanced imaging - MRI: other | Other | C2C | 59 | 4 | 6.8% |
| Air ambulance | Transportation | C2C | 58 | 8 | 13.8% |
| Wheelchairs | Other | C2C | 58 | 4 | 6.9% |
| Hospital beds and accessories | Other | C2C | 57 | 1 | 1.8% |
| Standard imaging - nuclear medicine | Other | C2C | 55 | 4 | 7.3% |
| Antidiabetic (e.g. Insulin, Glucophage) | Other | C2C | 52 | 1 | 1.9% |
| Dermatological agents | Other | C2C | 50 | 0 | 0.0% |
| specialist services | Physician Services | C2C | 47 | 1 | 2.1% |
| Restorations, any kind | Other | C2C | 44 | 0 | 0.0% |
| Antihyperlipidemics (e.g. Mevacor, Zocor | Other | C2C | 43 | 0 | 0.0% |
| Muscle Relaxants | Other | C2C | 40 | 1 | 2.5% |
| Continued Stay at SNF | Other | C2C | 39 | 1 | 2.6% |
| Routine office visit | Other | C2C | 39 | 1 | 2.6% |
| Cardiac Rehab | Non-MD Practitioner | C2C | 39 | 0 | 0.0% |
| Walkers | DME | C2C | 38 | 1 | 2.6% |
| Bath and toilet aids | Other | C2C | 36 | 0 | 0.0% |
| Analgesics (e.g. Vicodin) | Other | C2C | 36 | 0 | 0.0% |
| Immunomodulators (e.g. Interferon, Thalidomide) | Other | C2C | 35 | 1 | 2.9% |
| Bath and toilet aids | DME | C2C | 34 | 0 | 0.0% |
| Home Health Aide | Other | C2C | 32 | 1 | 3.1% |
| Cardiovascular agents | Other | C2C | 30 | 0 | 0.0% |
| Other preventive services | Other | C2C | 29 | 0 | 0.0% |
| Periodontal services | Other | C2C | 27 | 1 | 3.7% |
| Inpatient intensive care | Hospital Inpatient | C2C | 26 | 4 | 15.4% |
| Clinic Visit | Other | C2C | 26 | 0 | 0.0% |
| Acupuncture | Other | C2C | 25 | 2 | 8.0% |
| Antineoplastic agents | Drugs | C2C | 25 | 1 | 4.0% |
| Speech Therapy | Non-MD Practitioner | C2C | 23 | 2 | 8.7% |
| Jaw motion rehab system and accessories | Other | C2C | 22 | 0 | 0.0% |
| Home Health PT/OT | Home Health | C2C | 22 | 4 | 18.2% |
| Wheelchair - lightweight | Other | C2C | 21 | 2 | 9.5% |
| Admission to SNF | Skilled Nursing Facility | C2C | 21 | 1 | 4.8% |
| 2nd opinion | Other | C2C | 21 | 0 | 0.0% |
| Counseling | Other | C2C | 20 | 1 | 5.0% |
| Angiotensin II Receptor Antagonists (e.g. Cozaar, Diovan) | Other | C2C | 20 | 0 | 0.0% |
| Antirheumatic Agents (e.g. Methotrexate) | Drugs | C2C | 20 | 4 | 20.0% |
| Wheelchair - motorized | DME | C2C | 20 | 2 | 10.0% |
| OTC | Other | C2C | 20 | 1 | 5.0% |
| Standard imaging - other | Other | C2C | 20 | 0 | 0.0% |
| Patient lifts | DME | C2C | 19 | 2 | 10.5% |
| Extractions | Other | C2C | 19 | 2 | 10.5% |
| Other prostheses | Other | C2C | 18 | 2 | 11.1% |
| Follow-up care | Other | C2C | 16 | 2 | 12.5% |
| Vision aids | Other | C2C | 16 | 0 | 0.0% |
| Respiratory agents | Other | C2C | 15 | 0 | 0.0% |
| Antibiotics | Other | C2C | 15 | 0 | 0.0% |
| Infusion supplies | Other | C2C | 15 | 2 | 13.3% |
| Repairs and replacement supplies | Other | C2C | 14 | 0 | 0.0% |
| Crowns | Dental | C2C | 14 | 1 | 7.1% |
| Orthopedic Footwear (shoes, supports, lifts wedges, etc.) | Other | C2C | 14 | 0 | 0.0% |
| Podiatry treatment | Other | C2C | 14 | 1 | 7.1% |
| Glaucoma agents | Other | C2C | 13 | 1 | 7.7% |
| Wheelchair - fully reclining | Other | C2C | 13 | 0 | 0.0% |
| Wheelchair accessories | DME | C2C | 13 | 0 | 0.0% |
| Occupational therapy | Other | C2C | 13 | 0 | 0.0% |
| Topical Anti-infectives | Other | C2C | 13 | 0 | 0.0% |
| Preventive medicine services | Other | C2C | 12 | 1 | 8.3% |
| Transcutaneous and/or Neuromuscular Electrical Nerve Stimulators | DME | C2C | 12 | 1 | 8.3% |
| Inpatient other oncology tx | Other | C2C | 12 | 1 | 8.3% |
| Walkers | Other | C2C | 12 | 0 | 0.0% |
| Cardiac Rehab | Other | C2C | 12 | 0 | 0.0% |
| Wheelchair - heavy-duty | Other | C2C | 11 | 0 | 0.0% |
| Manual manipulation | Other | C2C | 11 | 0 | 0.0% |
| Patient lifts | Other | C2C | 11 | 0 | 0.0% |
| Advanced imaging - MRI: brain | Other | C2C | 11 | 1 | 9.1% |
| Prosthetic leg | Other | C2C | 11 | 0 | 0.0% |
| Hospitalist Services | Other | C2C | 10 | 2 | 20.0% |
| Enteral and IV Nutritional Therapy | Other | C2C | 10 | 0 | 0.0% |
| Bronchodilators (e.g. Albuterol, Alupent, Atrovent, Combivent) | Other | C2C | 10 | 0 | 0.0% |
| Root Canal | Other | C2C | 10 | 0 | 0.0% |
| Ultrasound lower | Other | C2C | 9 | 0 | 0.0% |
| Emergency services | Other | C2C | 9 | 0 | 0.0% |
| Inpatient Psych | Hospital Inpatient | C2C | 9 | 0 | 0.0% |
| Biphosphonates (e.g. Actonel, Fosamax) | Other | C2C | 9 | 0 | 0.0% |
| Speech Therapy | Other | C2C | 9 | 0 | 0.0% |
| Sex Hormones (e.g. Estrogen, Androgen, Testosterone) | Other | C2C | 8 | 0 | 0.0% |
| Pacemaker monitor | Other | C2C | 8 | 0 | 0.0% |
| Dietary instruction | Other | C2C | 8 | 0 | 0.0% |
| Orthotic procedures | Other | C2C | 8 | 0 | 0.0% |
| Hematological agents | Drugs | C2C | 8 | 0 | 0.0% |
| Renal and genitourinary agents | Other | C2C | 8 | 0 | 0.0% |
| Aide services | Other | C2C | 8 | 0 | 0.0% |
| Ankle-foot orthosis | Other | C2C | 8 | 0 | 0.0% |
| Urinalysis | Other | C2C | 8 | 0 | 0.0% |
| Decubitus care equipment | Other | C2C | 8 | 0 | 0.0% |
| Antidepressants (e.g. Zoloft) | Other | C2C | 7 | 0 | 0.0% |
| Safety equipment | Other | C2C | 7 | 1 | 14.3% |
| Anticholinergics (e.g. Ditropan) | Other | C2C | 7 | 0 | 0.0% |
| Injection of Synvisc or Hyalgen | Other | C2C | 7 | 0 | 0.0% |
| Inpatient radiation therapy | Other | C2C | 7 | 1 | 14.3% |
| Respiratory Treatment | Other | C2C | 7 | 0 | 0.0% |
| Anticonvulsants | Other | C2C | 7 | 0 | 0.0% |
| Prosthetic implants | Other | C2C | 7 | 1 | 14.3% |
| Anticoagulants (e.g. Coumadin, Heparin) | Other | C2C | 7 | 0 | 0.0% |
| Antianxiety Agents (e.g. Xanax) | Other | C2C | 7 | 0 | 0.0% |
| Taxi | Other | C2C | 7 | 0 | 0.0% |
| Inpatient diagnostic | Hospital Inpatient | C2C | 7 | 2 | 28.6% |
| Case management services | Other | C2C | 7 | 0 | 0.0% |
| Gastrointestinal agents | Drugs | C2C | 7 | 1 | 14.3% |
| IPPB machines | Other | C2C | 6 | 0 | 0.0% |
| Adjustments/repairs to removable prostheses (dentures) | Other | C2C | 6 | 0 | 0.0% |
| Standard imaging - musculoskeletal | Other | C2C | 6 | 0 | 0.0% |
| Knee orthosis | Other | C2C | 6 | 0 | 0.0% |
| X-rays | Other | C2C | 6 | 1 | 16.7% |
| Automated general profiles | Other | C2C | 6 | 0 | 0.0% |
| Critical care services | Other | C2C | 6 | 1 | 16.7% |
| hospital observation services | Other | C2C | 6 | 0 | 0.0% |
| Other treatments | Drugs | C2C | 6 | 0 | 0.0% |
| Suction Pump/room vaporizers, CPAP device | Other | C2C | 6 | 0 | 0.0% |
| Oral evaluation | Other | C2C | 6 | 0 | 0.0% |
| Antidiabetic (e.g. Insulin, Glucophage) | Drugs | C2C | 6 | 0 | 0.0% |
| Standard imaging - chest | Other | C2C | 6 | 0 | 0.0% |
| Pulmonary Rehab | Non-MD Practitioner | C2C | 6 | 1 | 16.7% |
| Antihyperlipidemics (e.g. Mevacor, Zocor | Drugs | C2C | 5 | 1 | 20.0% |
| Treat, No Transport | Other | C2C | 5 | 0 | 0.0% |
| Echography - heart | Other | C2C | 5 | 1 | 20.0% |
| Muscle Relaxants | Drugs | C2C | 5 | 0 | 0.0% |
| Topical Ophthalmic (eye) or otic (ear) agents | Drugs | C2C | 5 | 0 | 0.0% |
| Central nervous system | Drugs | C2C | 5 | 1 | 20.0% |
| Nutrients and Nutritional Agents | Other | C2C | 5 | 0 | 0.0% |
| Pulmonary Rehab | Physician Services | C2C | 5 | 0 | 0.0% |
| Heat/cold applications | Other | C2C | 5 | 0 | 0.0% |
| Analgesics (e.g. Vicodin) | Drugs | C2C | 5 | 0 | 0.0% |
| Other tests - cardiovascular stress tests | Other | C2C | 5 | 0 | 0.0% |
| Livery, ambulette | Other | C2C | 4 | 0 | 0.0% |
| Diuretics (e.g. Bumex, Lasix) | Other | C2C | 4 | 0 | 0.0% |
| Diagnostic services | Physician Services | C2C | 4 | 0 | 0.0% |
| Infusion supplies | DME | C2C | 4 | 2 | 50.0% |
| Other treatments | Hospital Inpatient | C2C | 4 | 1 | 25.0% |
| Advanced imaging - CAT: head | Other | C2C | 4 | 0 | 0.0% |
| Wheelchair - special size | Other | C2C | 4 | 0 | 0.0% |
| Antihistamines | Other | C2C | 4 | 0 | 0.0% |
| Emollients | Other | C2C | 4 | 0 | 0.0% |
| Knee-ankle-foot orthosis | Other | C2C | 4 | 0 | 0.0% |
| Intraocular lenses | Other | C2C | 4 | 0 | 0.0% |
| Massage Therapy | Other | C2C | 4 | 0 | 0.0% |
| Wheelchair Transportation | Other | C2C | 4 | 0 | 0.0% |
| Other tests - electrocardiograms | Other | C2C | 4 | 0 | 0.0% |
| Ultraviolet cabinet | Other | C2C | 4 | 0 | 0.0% |
| Dental surgical procedures | Dental | C2C | 4 | 0 | 0.0% |
| Personal Care Aide | Other | C2C | 4 | 0 | 0.0% |
| Nurse Practitioner | Other | C2C | 4 | 0 | 0.0% |
| Wheelchair - standard | Other | C2C | 4 | 0 | 0.0% |
| Surgical Assist | Physician Services | C2C | 3 | 1 | 33.3% |
| Vaccines (e.g. Travel vaccines) | Other | C2C | 3 | 0 | 0.0% |
| Contact lens | Other | C2C | 3 | 0 | 0.0% |
| Humidifiers/compressors/nebulizers for use with Oxygen | Other | C2C | 3 | 0 | 0.0% |
| Impotence Agents (e.g. Viagra, Caverject) | Other | C2C | 3 | 0 | 0.0% |
| Antiarrhythmic Agents (e.g. Mexitil) | Other | C2C | 3 | 0 | 0.0% |
| External Urinary Supplies | Other | C2C | 3 | 0 | 0.0% |
| Frames | Other | C2C | 3 | 0 | 0.0% |
| Incontinence Appliances and Care | Other | C2C | 3 | 0 | 0.0% |
| Diagnostic services | Drugs | C2C | 3 | 0 | 0.0% |
| Dentures | Dental | C2C | 3 | 0 | 0.0% |
| Respiratory Inhalants (e.g. Nasalide, Flovent) | Other | C2C | 3 | 0 | 0.0% |
| Home Health Aide | Home Health | C2C | 3 | 0 | 0.0% |
| Vitamins, Minerals, Electrolytes | Drugs | C2C | 3 | 0 | 0.0% |
| Immunomodulators (e.g. Interferon, Thalidomide) | Drugs | C2C | 3 | 0 | 0.0% |
| Wrist-hand-finger orthosis | Other | C2C | 3 | 0 | 0.0% |
| Bacterial cultures | Other | C2C | 3 | 0 | 0.0% |
| Pace maker | Other | C2C | 3 | 0 | 0.0% |
| Proton Pump Inhibitors (e.g. Prilosec) | Other | C2C | 3 | 0 | 0.0% |
| Other prostheses | DME | C2C | 3 | 0 | 0.0% |
| Periodontal services | Dental | C2C | 3 | 0 | 0.0% |
| Endocrine/Metabolic | Drugs | C2C | 3 | 0 | 0.0% |
| Antiplatelets (e.g. Ticlid) | Other | C2C | 3 | 0 | 0.0% |
| Nutrients and Nutritional Agents | Drugs | C2C | 2 | 0 | 0.0% |
| Admission to SNF | Hospital Inpatient | C2C | 2 | 0 | 0.0% |
| Physician Assistant | Other | C2C | 2 | 0 | 0.0% |
| Ultrasound upper | Other | C2C | 2 | 0 | 0.0% |
| Prosthetic leg | DME | C2C | 2 | 0 | 0.0% |
| Antipsychotic Agents | Other | C2C | 2 | 0 | 0.0% |
| Leg orthosis | Other | C2C | 2 | 0 | 0.0% |
| Standard imaging - breast | Other | C2C | 2 | 0 | 0.0% |
| Blood counts | Other | C2C | 2 | 0 | 0.0% |
| Transcutaneous and/or Neuromuscular Electrical Nerve Stimulators | Physician Services | C2C | 2 | 1 | 50.0% |
| Antineoplastic agents | DME | C2C | 2 | 0 | 0.0% |
| Breast prostheses | Other | C2C | 2 | 0 | 0.0% |
| Glucose | Other | C2C | 2 | 0 | 0.0% |
| Physical Therapy | Home Health | C2C | 2 | 1 | 50.0% |
| Inpatient diagnostic | Physician Services | C2C | 2 | 0 | 0.0% |
| Prosthetic procedures - upper and lower limbs | Other | C2C | 2 | 0 | 0.0% |
| Antibiotics (e.g. Ceftin) | Other | C2C | 2 | 0 | 0.0% |
| Calcium Channel Blockers (e.g. Cardizem, Verapamil) | Other | C2C | 2 | 0 | 0.0% |
| Penile implant | Other | C2C | 2 | 0 | 0.0% |
| Inpatient intensive care | DME | C2C | 2 | 2 | 100.0% |
| Miscellaneous | DME | C2C | 2 | 0 | 0.0% |
| Continued Stay at SNF | Home Health | C2C | 2 | 0 | 0.0% |
| Prophylaxis | Other | C2C | 2 | 1 | 50.0% |
| Monitoring equipment, blood glucose monitors | Non-MD Practitioner | C2C | 2 | 0 | 0.0% |
| Acute rehabilitation | Skilled Nursing Facility | C2C | 2 | 0 | 0.0% |
| Wheelchair - semi-reclining | Other | C2C | 2 | 0 | 0.0% |
| Advanced imaging - MRI: brain | Diagnostic Imaging | C2C | 2 | 2 | 100.0% |
| Admission to SNF | Home Health | C2C | 2 | 0 | 0.0% |
| Echography - other | Other | C2C | 2 | 0 | 0.0% |
| Specialist services | DME | C2C | 2 | 1 | 50.0% |
| Treatment of fractures | Other | C2C | 2 | 0 | 0.0% |
| Acute rehabilitation | Non-MD Practitioner | C2C | 2 | 0 | 0.0% |
| Specialist services | Out of Area | C2C | 2 | 1 | 50.0% |
| Repairs and replacement supplies | DME | C2C | 2 | 0 | 0.0% |
| Thrombolytic Agents (e.g. TPA, Streptokinase, etc.) | Other | C2C | 2 | 0 | 0.0% |
| Prosthetic eye | Other | C2C | 2 | 0 | 0.0% |
| Acute rehabilitation | DME | C2C | 2 | 0 | 0.0% |
| Home Health PT/OT | Physician Services | C2C | 1 | 0 | 0.0% |
| Vitamins, Minerals, Electrolytes | Physician Services | C2C | 1 | 0 | 0.0% |
| Specific Drug | DME | C2C | 1 | 0 | 0.0% |
| Whirlpool equipment | Other | C2C | 1 | 0 | 0.0% |
| Removal of tumors, cysts and neoplasms | Other | C2C | 1 | 0 | 0.0% |
| Spectacle lenses | Other | C2C | 1 | 0 | 0.0% |
| Incontinence Appliances and Care | DME | C2C | 1 | 0 | 0.0% |
| X-rays | Dental | C2C | 1 | 0 | 0.0% |
| Anticholinergics (e.g. Ditropan) | Drugs | C2C | 1 | 0 | 0.0% |
| Biologic and immunologic agents | Physician Services | C2C | 1 | 0 | 0.0% |
| Biphosphonates (e.g. Actonel, Fosamax) | Drugs | C2C | 1 | 0 | 0.0% |
| Other treatments | Laboratory | C2C | 1 | 0 | 0.0% |
| Immunomodulators (e.g. Interferon, Thalidomide) | Physician Services | C2C | 1 | 0 | 0.0% |
| Aide services | Physician Services | C2C | 1 | 0 | 0.0% |
| Central nervous system | Physician Services | C2C | 1 | 0 | 0.0% |
| Standard imaging - other | Diagnostic Imaging | C2C | 1 | 0 | 0.0% |
| Routine venipuncture | Other | C2C | 1 | 1 | 100.0% |
| Antirheumatic Agents (e.g. Methotrexate) | DME | C2C | 1 | 0 | 0.0% |
| Advanced imaging - CAT: other | Non-MD Practitioner | C2C | 1 | 0 | 0.0% |
| Clinic Visit | Physician Services | C2C | 1 | 0 | 0.0% |
| Specialist services | Hospital Inpatient | C2C | 1 | 0 | 0.0% |
| Glaucoma agents | Drugs | C2C | 1 | 1 | 100.0% |
| Antidiabetic (e.g. Insulin, Glucophage) | Physician Services | C2C | 1 | 0 | 0.0% |
| Monitoring equipment, blood glucose monitors | Medical Supplies | C2C | 1 | 0 | 0.0% |
| Other treatments | Home Health | C2C | 1 | 1 | 100.0% |
| 2nd opinion | Out of Area | C2C | 1 | 0 | 0.0% |
| Restorations, any kind | Dental | C2C | 1 | 0 | 0.0% |
| Echography - prostate, transrectal | Diagnostic Imaging | C2C | 1 | 0 | 0.0% |
| Chemotherapy agents | Physician Services | C2C | 1 | 0 | 0.0% |
| Home Health Nursing | Hospital Inpatient | C2C | 1 | 0 | 0.0% |
| Taxi | Transportation | C2C | 1 | 0 | 0.0% |
| Leukotriene Receptor Antagonists (e.g. Singulair, Accolate) | Other | C2C | 1 | 0 | 0.0% |
| Wigs (sometimes, cranial prosthesis) | Other | C2C | 1 | 0 | 0.0% |
| Antidepressants (e.g. Zoloft) | Drugs | C2C | 1 | 0 | 0.0% |
| Crutches | Other | C2C | 1 | 0 | 0.0% |
| Other lab tests | Diagnostic Imaging | C2C | 1 | 0 | 0.0% |
| Swing Bed | Other | C2C | 1 | 0 | 0.0% |
| Echography - carotid arteries | Other | C2C | 1 | 0 | 0.0% |
| Oxygen and respiratory equipment | Other | C2C | 1 | 0 | 0.0% |
| Surgical Assist | Hospital Inpatient | C2C | 1 | 0 | 0.0% |
| Sex Hormones (e.g. Estrogen, Androgen, Testosterone) | Drugs | C2C | 1 | 0 | 0.0% |
| Other treatments | Out of Area | C2C | 1 | 0 | 0.0% |
| Specific Drug | Other | C2C | 1 | 0 | 0.0% |
| Cardiovascular agents | Drugs | C2C | 1 | 0 | 0.0% |
| Orthotic procedures | Prosthetics/Orthotics | C2C | 1 | 0 | 0.0% |
| Systemic anti-infectives [note that dermatological anti-infectives as well as ophthalmic and otic anti-infectives are classified separately under classes R110 and R111 respectively] | Other | C2C | 1 | 0 | 0.0% |
| Crutches | DME | C2C | 1 | 0 | 0.0% |
| Water ambulance | Other | C2C | 1 | 0 | 0.0% |
| Root Canal | Dental | C2C | 1 | 0 | 0.0% |
| Wheelchair - heavy-duty | DME | C2C | 1 | 0 | 0.0% |
| Other tests - EKG monitoring | Other | C2C | 1 | 0 | 0.0% |
| Wheelchair - lightweight | DME | C2C | 1 | 0 | 0.0% |
| Consultation | Physician Services | C2C | 1 | 0 | 0.0% |
| Back Brace | Other | C2C | 1 | 0 | 0.0% |
| Long-tern acute care | Non-MD Practitioner | C2C | 1 | 0 | 0.0% |
| H2 Antagonists ( e.g. Pepcid) | Other | C2C | 1 | 0 | 0.0% |
| Glucose | DME | C2C | 1 | 1 | 100.0% |
| Other treatments | DME | C2C | 1 | 0 | 0.0% |
| Air ambulance | Other | C2C | 1 | 0 | 0.0% |
| Wheelchair Transportation | Transportation | C2C | 1 | 0 | 0.0% |
| Angiotensin II Receptor Antagonists (e.g. Cozaar, Diovan) | Drugs | C2C | 1 | 0 | 0.0% |
| Prosthetic implants | DME | C2C | 1 | 0 | 0.0% |
| Emergency ambulance | Other | C2C | 1 | 0 | 0.0% |
| Miscellaneous services | Medical Supplies | C2C | 1 | 0 | 0.0% |
| Hematological agents | Physician Services | C2C | 1 | 0 | 0.0% |
| Consultation | Out of Area | C2C | 1 | 0 | 0.0% |
| Specific Drug | Physician Services | C2C | 1 | 0 | 0.0% |
| Consultation | Vision Care | C2C | 1 | 0 | 0.0% |
| Imaging - other | Drugs | C2C | 1 | 0 | 0.0% |
| Rollabout chair | Other | C2C | 1 | 0 | 0.0% |
| Antineoplastic agents | Hospital Inpatient | C2C | 1 | 1 | 100.0% |
| Emergency services | Hospital Inpatient | C2C | 1 | 0 | 0.0% |
| Pacemaker monitor | DME | C2C | 1 | 0 | 0.0% |
| Test & Lab examinations | Dental | C2C | 1 | 0 | 0.0% |
| Specialist services | Diagnostic Imaging | C2C | 1 | 0 | 0.0% |
| Inpatient intensive care | Drugs | C2C | 1 | 1 | 100.0% |
| Decubitus care equipment | DME | C2C | 1 | 0 | 0.0% |
| Admission to SNF | Non-MD Practitioner | C2C | 1 | 0 | 0.0% |
| Antirheumatic Agents (e.g. Methotrexate) | Dental | C2C | 1 | 0 | 0.0% |
| Specialist services | Non-MD Practitioner | C2C | 1 | 0 | 0.0% |
| Test & Lab examinations | Other | C2C | 1 | 0 | 0.0% |
| Respiratory Inhalants (e.g. Nasalide, Flovent) | Drugs | C2C | 1 | 1 | 100.0% |
| Dental surgical procedures | Physician Services | C2C | 1 | 0 | 0.0% |
| Dermatological agents | Drugs | C2C | 1 | 0 | 0.0% |
| Wheelchair - amputee | Other | C2C | 1 | 0 | 0.0% |
| Commodes | Other | C2C | 1 | 0 | 0.0% |
| Cataract Glasses | Other | C2C | 1 | 0 | 0.0% |
| Inpatient intensive care | Physician Services | C2C | 1 | 0 | 0.0% |
| Non-emergency ambulance | DME | C2C | 1 | 0 | 0.0% |
| Podiatry treatment | Home Health | C2C | 1 | 0 | 0.0% |
| Restorations, any kind | Non-MD Practitioner | C2C | 1 | 0 | 0.0% |
| Restraints, any type | Other | C2C | 1 | 0 | 0.0% |
| Monitoring equipment, blood glucose monitors | Hospital Inpatient | C2C | 1 | 1 | 100.0% |
| Extractions | Dental | C2C | 1 | 0 | 0.0% |
| Power Operated Vehicle | Non-MD Practitioner | C2C | 1 | 0 | 0.0% |
| Proton Pump Inhibitors (e.g. Prilosec) | Drugs | C2C | 1 | 0 | 0.0% |
| MRA upper | Diagnostic Imaging | C2C | 1 | 0 | 0.0% |
| Acute Inpatient Rehab | Inpatient Hospital | Maximus | 36,225 | 406 | 1.1% |
| Dental | Supplemental Benefit | Maximus | 25,417 | 557 | 2.2% |
| Other | Lab | Maximus | 19,421 | 378 | 1.9% |
| Other | Surgery | Maximus | 16,601 | 1,360 | 8.2% |
| Diabetic Supplies | DME/ Orthotics | Maximus | 16,419 | 331 | 2.0% |
| Other | Practitioner Services | Maximus | 16,074 | 428 | 2.7% |
| Office Visit | Practitioner Services | Maximus | 15,554 | 224 | 1.4% |
| Genetic Testing | Lab | Maximus | 12,129 | 496 | 4.1% |
| Other | DME/ Orthotics | Maximus | 9,569 | 516 | 5.4% |
| LTACH | Inpatient Hospital | Maximus | 8,765 | 20 | 0.2% |
| General Health Panel | Lab | Maximus | 5,971 | 84 | 1.4% |
| Transportation | Supplemental Benefit | Maximus | 5,941 | 20 | 0.3% |
| Acute Inpatient | Inpatient Hospital | Maximus | 5,701 | 589 | 10.3% |
| Power Mobility Devices | DME/ Orthotics | Maximus | 5,212 | 158 | 3.0% |
| Other | Drugs | Maximus | 3,796 | 312 | 8.2% |
| Injections | Practitioner Services | Maximus | 3,514 | 169 | 4.8% |
| Pre-Service Part B-Drug | Drugs | Maximus | 3,400 | 143 | 4.2% |
| Physical Therapy | Outpatient Therapies | Maximus | 3,216 | 102 | 3.2% |
| Brain and Spine | Surgery | Maximus | 2,914 | 107 | 3.7% |
| Ambulance | Transportation | Maximus | 2,605 | 68 | 2.6% |
| Joint/Bone Surgery | Surgery | Maximus | 2,445 | 146 | 6.0% |
| Other | Imaging | Maximus | 2,367 | 147 | 6.2% |
| Other | Testing | Maximus | 2,060 | 66 | 3.2% |
| CT Scan | Imaging | Maximus | 1,912 | 183 | 9.6% |
| Wound Care | Practitioner Services | Maximus | 1,865 | 305 | 16.4% |
| Self Administered | Drugs | Maximus | 1,804 | 3 | 0.2% |
| Vision Care | Supplemental Benefit | Maximus | 1,722 | 88 | 5.1% |
| Oxygen Equipment | DME/ Orthotics | Maximus | 1,704 | 50 | 2.9% |
| Other | Supplemental Benefit | Maximus | 1,615 | 99 | 6.1% |
| PET Scan | Imaging | Maximus | 1,529 | 266 | 17.4% |
| Anesthesia | Practitioner Services | Maximus | 1,499 | 59 | 3.9% |
| Pain Management | Practitioner Services | Maximus | 1,411 | 56 | 4.0% |
| Chiropractic Care | Practitioner Services | Maximus | 1,410 | 31 | 2.2% |
| Drug Testing | Lab | Maximus | 1,381 | 53 | 3.8% |
| X-Ray | Imaging | Maximus | 1,337 | 38 | 2.8% |
| Ultrasound | Testing | Maximus | 1,335 | 36 | 2.7% |
| Inpatient Mental Health | Inpatient Hospital | Maximus | 1,245 | 45 | 3.6% |
| Out of Area | Practitioner Services | Maximus | 1,227 | 9 | 0.7% |
| Acupuncture | Practitioner Services | Maximus | 1,128 | 31 | 2.7% |
| MRI | Imaging | Maximus | 1,113 | 152 | 13.7% |
| Pneumatic Compression Dev | DME/ Orthotics | Maximus | 1,068 | 39 | 3.7% |
| Radiation Therapy | Practitioner Services | Maximus | 976 | 174 | 17.8% |
| Extremity Brace | DME/ Orthotics | Maximus | 939 | 40 | 4.3% |
| Other | Inpatient Hospital | Maximus | 888 | 58 | 6.5% |
| Foot Orthotics | DME/ Orthotics | Maximus | 869 | 45 | 5.2% |
| Ambulance - Non Emergent | Transportation | Maximus | 816 | 36 | 4.4% |
| Pneumatic Compression Device | DME/ Orthotics | Maximus | 800 | 41 | 5.1% |
| Hearing Aids | Supplemental Benefit | Maximus | 715 | 18 | 2.5% |
| Cardiovascular Disease | Practitioner Services | Maximus | 682 | 26 | 3.8% |
| Manual Wheelchair | DME/ Orthotics | Maximus | 670 | 28 | 4.2% |
| EKG | Imaging | Maximus | 553 | 17 | 3.1% |
| Eye | Surgery | Maximus | 544 | 17 | 3.1% |
| Pain Management | Drugs | Maximus | 469 | 21 | 4.5% |
| CPAP | DME/ Orthotics | Maximus | 464 | 30 | 6.5% |
| Chemotherapy | Drugs | Maximus | 458 | 60 | 13.1% |
| Other | Transportation | Maximus | 431 | 16 | 3.7% |
| Colonoscopy | Testing | Maximus | 426 | 14 | 3.3% |
| Neck/Back | DME/ Orthotics | Maximus | 414 | 8 | 1.9% |
| Plastic Surgery | Surgery | Maximus | 382 | 28 | 7.3% |
| Specialty vs. Primary Care | Practitioner Services | Maximus | 381 | 9 | 2.4% |
| Mammography | Imaging | Maximus | 374 | 4 | 1.1% |
| Nuclear Stress Test | Testing | Maximus | 368 | 3 | 0.8% |
| Endoscopy | Testing | Maximus | 352 | 14 | 4.0% |
| Preventive Services | Practitioner Services | Maximus | 349 | 18 | 5.2% |
| Services Not Covered | Practitioner Services | Maximus | 321 | 12 | 3.7% |
| Ambulance - Air | Transportation | Maximus | 311 | 74 | 23.8% |
| Walker | DME/ Orthotics | Maximus | 277 | 5 | 1.8% |
| Immunizations | Practitioner Services | Maximus | 265 | 3 | 1.1% |
| Lower Limb Prostheses | DME/ Orthotics | Maximus | 260 | 26 | 10.0% |
| Experimental/Investigational | Practitioner Services | Maximus | 254 | 25 | 9.8% |
| Shower/Bath Chair | DME/ Orthotics | Maximus | 252 | 0 | 0.0% |
| ESRD Services | Practitioner Services | Maximus | 247 | 14 | 5.7% |
| CTA | Imaging | Maximus | 239 | 34 | 14.2% |
| Gym Membership | Supplemental Benefit | Maximus | 214 | 11 | 5.1% |
| Cardiac Rehab | Outpatient Therapies | Maximus | 200 | 4 | 2.0% |
| Occupational Therapy | Outpatient Therapies | Maximus | 198 | 8 | 4.0% |
| Compression Stockings | DME/ Orthotics | Maximus | 191 | 6 | 3.1% |
| Sleep Study | Testing | Maximus | 170 | 17 | 10.0% |
| Seat Lift Mechanism | DME/ Orthotics | Maximus | 170 | 5 | 2.9% |
| Non-Physician Provider | Practitioner Services | Maximus | 158 | 6 | 3.8% |
| Critical Care | Inpatient Hospital | Maximus | 127 | 3 | 2.4% |
| OTC (Over-The-Counter) | Supplemental Benefit | Maximus | 121 | 4 | 3.3% |
| Speech Therapy | Outpatient Therapies | Maximus | 118 | 14 | 11.9% |
| Immunology | Drugs | Maximus | 109 | 21 | 19.3% |
| Post Stabilization | Inpatient Hospital | Maximus | 95 | 8 | 8.4% |
| DEXA | Imaging | Maximus | 74 | 3 | 4.1% |
| Rheumatology | Drugs | Maximus | 71 | 4 | 5.6% |
| Pulmonary Disease | Practitioner Services | Maximus | 31 | 2 | 6.5% |
| Pulmonary Rehab | Outpatient Therapies | Maximus | 27 | 1 | 3.7% |
| PET Scan | Testing | Maximus | 25 | 4 | 16.0% |
| Worldwide | Supplemental Benefit | Maximus | 12 | 0 | 0.0% |
"Other" is the fact sheets' catch-all, within each type of service and, for C2C, as a type of its own. Items with few decisions swing a lot from quarter to quarter.